# Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production

> **NCT04268953** · PHASE1 · COMPLETED · sponsor: **Cerecin** · enrollment: 12 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Tricaprilin

## Key facts

- **NCT ID:** NCT04268953
- **Lead sponsor:** Cerecin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-27
- **Primary completion:** 2020-03-26
- **Final completion:** 2020-05-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04268953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04268953, "Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04268953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*